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Diagnosing lung function abnormalities requires application of the appropriate reference equa-
tion for a given patient population. Current guidelines recommend the National Health and
Examination Study III data set for evaluating patients in the United States. In Caucasian
patients, relying on older reference equations, as opposed to those derived from the NHANES
III data set, will often result in a different interpretation of a patient’s spirometry. The present
study assessed whether similar discordance would occur in AfricaneAmerican patients.
A cross-sectional analysis of AfricaneAmerican patients undergoing spirometry testing at our
hospital was performed. Patients were classified as normal, restricted, obstructed or mixed
based upon the ATS/ERS guidelines, using Crapo, Knudson, Morris, Glindmeyer, and NHANES
III prediction equations. Differences in classification were evaluated.
4463 subjects were identified, with a mean age of 49.6. Discordance in interpretation was
most common when results from prediction equations by Morris, Knudson, and Glindmeyer
were compared to NHANES III (24.6%, 26.4%, and 20.1%, respectively). Discordance was less
common when comparing Crapo to NHANES III (12.8%). There was a tendency for Knudson,
Morris and Glindmeyer to under classify restriction, and for Crapo, Morris, and Glindmeyer
to over classify obstruction.r are those of the authors and do not reflect the official policy of the Department of the Army,
vernment.
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In 2005, the American Thoracic Society (ATS) and the
European Respiratory Society (ERS) published new,
combined guidelines recommending the use of reference
values from the National Health and Nutrition Examination
Study III (NHANES III) data set1 for all patients in the United
States between the ages of 8 and 80.2 Switching from older
reference equations to NHANES III results in differences in
disease classification and severity without an actual change
in disease status in a Caucasian population.3 Our group
recently performed a cross-sectional analysis of the non-
Hispanic Caucasian patients in our hospital’s spirometry
database to assess for diagnostic reclassification when
adopting the ATS/ERS guidelines.2 We found that reference
equations from Crapo,4 Knudson,5 and Morris6 commonly
under classify restriction (‘restrictive pattern’) and over
classify obstruction7 in comparison to the NHANES III
equations.1 This discordance in classification may create
uncertainty for clinicians using spirometry to confirm or
exclude pulmonary disease.
It is well known that differences in lung volumes exist
between Caucasians and blacks in Africa.8e12 Historically,
pulmonary laboratories have applied standard conversions
to commonly used reference equations4e6,13 when testing
AfricaneAmerican patients (multiplying the FVC and FEV1
by a conversion factor of 0.88).14 These standard conver-
sions are based on prior studies showing that Africane
Americans have FEV1 and FVC values approximately 12%
lower than Caucasians.14 These studies did not include
patients older than 65 years, and a later study by Enright
and colleagues15 found that AfricaneAmericans older than
65 years have FVC values approximately 6% lower than
Caucasions. Reference equations for blacks have been
created, but most are based on populations of blacks in
Africa16e18 with only one set derived from a very specific,
blue-collar AfricaneAmerican population in the United
States.19 It is not clear whether any of these equations
would be appropriate for use throughout the United States.
Prior to publication of NHANES III, most reference
equations were derived from small, homogenous
populations that were tested in the 1970s and 80s. A study
of pulmonary training programs in the United States,
published in 1990, indicated that most labs were using
correction factors when evaluating AfricaneAmerican
patients,20 as opposed to using reference equations derived
specifically from AfricaneAmerican populations. In 1995,
Glindmeyer et al19 published a set of reference equations
derived from AfricaneAmericans working at a paper plant
in Louisiana. It is unclear whether or to what extent
occupational respiratory inhalant exposure could have
impacted their results, although the authors due attempt
to account for this in the manuscript. To our knowledge,
with the exception of NHANES III, this is the largest studyon normal spirometry values for AfricaneAmericans in
the US.
We hypothesized that NHANES III would produce signifi-
cantly different reference ranges for normal spirometry in
AfricaneAmericans in the US, when compared to the older
equations. Our goal was to assess for discordance between
normal values defined by NHANES III versus racially cor-
rected normal values defined by Crapo, Knudson, and
Morris. Because it is not known how often they are used in
the United States, we compared the reference ranges
defined by the Glindmeyer equations to NHANES III as well.
Materials and methods
We conducted a retrospective review of all adult, Africane
American patients undergoing spirometry testing at Walter
Reed Army Medical Center, from January 2000 to May 2007.
Referrals for symptoms, pre-operative screening, and
routine follow-up after treatment are all common, and
testing is ordered by physicians from all services (a
pulmonary consult is not required). The presence or
absence of symptoms during testing was not documented.
AfricaneAmerican patients were identified by self-report at
the time of testing.
All spirometry (Vmax, 6200 Autobox DL, Sensormedics,
Yorba Linda, CA) was performed according to American
Thoracic Society (ATS) standards.21 Prior to 2005, spiro-
metric end of test criteria was based on the 1994 ATS
standards.22 Measured spirometric indices for individual
patients were interpreted using the equations published by
Crapo,4 Knudson,5 Morris,6 Glindmeyer,19 and NHANES III.1
Expected values for forced vital capacity (FVC) and forced
expiratory volume in 1 s (FEV1) were multiplied by
a conversion factor of 0.88 for Crapo, Knudson, and Morris
equations. No conversion factor was required for the
Glindmeyer and NHANES III equations because they were
both derived directly from AfricaneAmerican populations.
All patients were (re)classified using an algorithm similar to
the ATS/ERS recommended algorithm for spirometric
interpretation.2
This study was designed to assess differences in pattern
classification. A restrictive pattern was defined by an FVC
outside the lower end of the 95% confidence interval, or
lower limit of normal (LLN), calculated using the methods
described in the Crapo, Knudson, Morris, Glindmeyer, and
NHANES III studies. Severity of restriction was graded based
on degree of decrement in FVC below the LLN, in accor-
dance with the 1986 ATS guidelines.23 As such, an FVC of
60e80% predicted was graded as ‘‘mild severity,’’ 50e59%
predicted was ‘‘moderate,’’ and less than 50% predicted
was ‘‘severe.’’ An obstructive defect was defined by an
FEV1/FVC ratio below the lower end of the 95% confidence
interval (LLN) for each reference equation, with severity
based on the degree of decrement in FEV1 according to
Table 1 Patient demographics.
Mean (SD) Range
Males n Z 2283 (51.2%)
Age 49.7 (17.1) 19e91
Height (cm) 177.5 (7.2) 152.4e200.7
Weight (kg) 91.2 (17) 46.4e156.8
BMI 28.9 (4.9) 15.8e51.8
FEV1 2.7 (0.9) 0.30e5.2
FVC 3.7 (1.0) 0.6e6.7
FEV1/FVC 73.8 (11.5) 23e100
Females n Z 2180 (48.9%)
Age 49.4 (16.6) 19e91
Height (cm) 163.4 (6.7) 129.5e188
Weight (kg) 77.1 (17.3) 36.8e181.8
BMI 28.9 (6.2) 13.3e73.3
FEV1 2.0 (0.6) 0.3e4.2
FVC 2.6 (0.7) 0.4e5.1
FEV1/FVC 75.9 (11.3) 26e100
Racial discordance in spirometry 707ATS/ERS 2005 guidelines.2 As such, an FEV1 > 70% predicted
was graded as ‘‘mild severity,’’ 60e69% predicted as
‘‘moderate,’’ 50e59% predicted as ‘‘moderately severe,’’
35e49% predicted as ‘‘severe,’’ and <35% predicted as
‘‘very severe.’’ Patients with both an obstructive and
a restrictive defect were categorized as having a mixed
pattern, with severity based on the same scale of decre-
ment in FEV1 that was used for those categorized with an
obstructive defect.
This protocol was approved by the Department of
Clinical Investigation at our hospital.
Statistics
Relationships between continuous and categorical variables
were assessed using Student’s t test and chi-square test
respectively. Agreement on interpretation of spirometry
(normal, obstructive, restrictive, or mixed) between
predictive models was assessed using kappa. Agreement on
severity of obstruction and restriction was assessed using
quadratic kappa. Reported p-values are two-sided. Statis-
tical significance was defined as p < 0.05. All analyses were
performed using STATA ver. 9.2 (StataCorp LP, College
Station, TX). Multivariate logistic regression was used to
calculate adjusted odds ratios for discordance between
interpretative strategies using equations by Crapo, Knud-
son, Morris, and Glindmeyer against those from NHANES III.
Covariates included in logistic regression models included
sex, age (<25, 25e34.9, 35e49.9, 50e64.9, 65e79.9, 80),
BMI (<18.5, 18e24.9, 25e29.9, 30e40, 40), short stature
(height in the lowest 2.5% for gender), or tall stature
(height in the highest 2.5% for gender).
Results
14,390 pulmonary function tests were performed at our
facility during the study period. The majority of subjects
were Caucasians (n Z 8733; 60.7%) with the remainder
categorized as AfricaneAmerican (n Z 4463; 31.0%),
Hispanic (n Z 667; 4.6%), and Asian (n Z 527, 3.7%). This
study is limited to exploring discordance among Africane
Americans. Demographic information on the patients
included in our study is listed in Table 1.
Concordant classification was observed in 87.2%, 73.6%,
75.4%, and 80% when comparing Crapo, Knudson, Morris,
and Glindmeyer, respectively, to NHANES III. The two most
common patterns of reclassification were from normal by
Knudson, Morris, and Glindmeyer to restricted by NHANES
III, and from obstructed by Crapo, Morris, and Glindmeyer
to normal by NHANES III. A third major category of reclas-
sification was from restricted by Crapo to normal by
NHANES III (Figs. 1 and 2).
The severity of restriction was mild for the majority of
patients who were reclassified from normal by Knudson,
Morris, or Glindmeyer to restrictive by NHANES III. For
patients who were reclassified from obstructed by Crapo,
Morris, or Glindmeyer to normal by NHANES III, the majority
of defects were also mild.
Evaluation of agreement in diagnostic classification
between NHANES III and Crapo was excellent
(KappaZ 0.80), fair-to-good with Knudson (KappaZ 0.47),fair-to-good with Morris (Kappa Z 0.53), and good-to-
excellent with Glindmeyer (Kappa Z 0.67). Measures of
obstruction and restriction severity were excellent
between Crapo, Knudson, Morris, and Glindmeyer and
NHANES III (Kappas ranged from 0.81 to 0.95).
Classification of discordance between Crapo, Knudson,
Morris, Glindmeyer, and NHANES III was also evaluated by
gender. Agreement between classifications was excellent
between Crapo and NHANES III for both males and females,
but was higher in males (Kappa Z 0.85), than in females
(KappaZ 0.73). Females (nZ 223, 41.3%) were more likely
than males (n Z 69, 13.2%) to be reclassified from
restrictve by Crapo to normal by NHANES III. Agreement
with Knudson was identical for males and females
(kappaZ 0.47), while females were slightly less likely to be
discordant for both Morris (kappa females Z 0.54; kappa
males Z 0.52) and Glindmeyer (kappa females Z 0.69;
kappa males Z 0.64).
Predictors of discordance included gender, older age,
short stature, and obesity (Table 2). Females were less
likely to be reclassified than males when comparing Knud-
son (OR Z 0.66; 95% CI Z 0.57e0.76), Morris (OR Z 0.68;
95% CI Z 0.59e0.78), and Glindmeyer (OR Z 0.67; 95%
CIZ 0.57e0.78) to NHANES III. Females were more likely to
be reclassified when comparing interpretations from Crapo
to those from NHANES III (ORZ 1.78; 95% CIZ 1.48e2.13).
Age greater than 65 predicted higher rates of discordance
for all equations. Short stature was protective against
discordance when using the Knudson, Morris and Glind-
meyer equations. Being overweight (BMI > 30) predicted
discordance when using the equations by Knudson and
Morris.
Discussion
In this population of 4463 AfricaneAmerican patients, we
found significant discordance in the spirometric interpre-
tations between older reference standards and NHANES III.
Discordant classification was found in over 20% of the
Figure 1 Discordant classifications.
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(Knudson), and was higher in specific groups. Gender, age
greater than 65, obesity (BMI > 30), and short stature were
all predictors of discordance.
Both the number of reclassifications and the change in
interpretation patterns are clinically important, with the
potential for altered diagnoses without a change in clinical
status, and flawed evaluation and management. For
example, Crapo showed a tendency to over classify females
as having a restrictive pattern in our population. This could
lead to inappropriate evaluations for restrictive lung
disease, to include inappropriate imaging and radiation
exposure. Knudson, Morris and Glindmeyer tended to under
classify restrictive patterns in our population, with theFigure 2 Patterns of spirometric discordance.potential for missed diagnoses. Unless all laboratories are
currently using NHANES III, individuals undergoing spirom-
etry as part of an initial work-up may experience unnec-
essary referrals, or may not be referred when needed. With
groups now recommending screening and office based
spirometry for different clinical scenarios,24,25 results will
increasingly be read by physicians not specifically trained in
the nuances of spirometric interpretation. In this case,
unexpected changes in reference standards could have
a particularly large impact on missed diagnoses, and inap-
propriate referrals, tests, and treatments.
From a researchers’ perspective, widespread imple-
mentation of the new ATS/ERS guidelines may result in
different patient populations being studied. The results
from populations defined by the older criteria may not be
applicable to current patient populations. Additionally,
spirometric measures presented as percent predicted could
potentially affect disability ratings.23 Lung transplantation
referrals26 and pre-operative risk assessments27 may be
affected when FEV1 or FVC values fall near cut-offs
required for eligibility.
The reasons for discordance between older studies and
NHANES III cannot be determined with certainty. The
populations studied by Crapo and Morris consisted mainly of
members of The Church of Jesus Christ of Latter Day Saints
(Mormons), who were selected for their decreased expo-
sure to air pollution and tobacco smoke. The patients
studied by Glindmeyer all worked at a paper processing
plant in Louisiana and were of a similar socioeconomic
status. In both cases, the populations would be considered
homogenous in comparison to NHANES III, making their
equations less generalizable to different groups across
the US.
Technical and procedural differences could account for
significant discordance. NHANES III required a five-
maneuver minimum, and when they re-analyzed their own
data using 1994 ATS guidelines (three acceptable curves
Table 2 Adjusted odds ratios for interpretative discordance between various prediction equations and equations by NHANES
III.
Crapo 95% CI Knudson 95% CI Morris 95% CI Glindmeyer 95% CI
Male 1.00 e 1.00 e 1.00 e 1.00 e
Female 1.78y 1.48e2.13 0.66y 0.57e0.76 0.68y 0.59e0.78 0.67y 0.57e0.78
Age
35e50 1.00 e 1.00 e 1.00 e 1.00 e
<25 1.49* 1.02e2.19 0.84 0.60e1.16 1.43* 1.05e1.94 0.76 0.50e1.15
25e35 1.06 0.78e1.44 0.98 0.79e1.23 1.12 0.89e1.42 0.60* 0.44e0.82
50e65 1.28 1.00e1.66 1.20 1.00e1.44 1.30* 1.07e1.58 1.91y 1.54e2.35
65e80 2.17y 1.70e2.76 1.64y 1.36e1.98 2.17y 1.79e2.63 3.85y 3.14e4.73
>80 2.60y 1.70e3.98 1.85* 1.30e2.63 2.26y 1.58e3.23 4.20y 2.94e6.01
Short 0.55 0.29e1.03 0.43* 0.27e0.71 0.43* 0.26e0.71 0.45* 0.26e0.76
Tall 0.89 0.48e1.64 1.10 0.73e1.68 1.10 0.71e1.69 1.23 0.77e1.98
BMI
25e30 1.00 e 1.00 e 1.00 e 1.00 e
<18.5 0.67 0.26e1.73 1.80 0.93e3.45 1.18 0.58e2.41 1.27 0.63e2.58
18.5e25 0.96 0.76e1.22 1.12 0.93e1.35 1.03 0.85e1.25 0.98 0.79e1.21
30e40 0.85 0.68e1.05 1.43y 1.22e1.67 1.44y 1.22e1.69 1.17 0.98e1.40
>40 1.03 0.66e1.62 2.30y 1.64e3.22 2.17y 1.54e3.06 1.20 0.81e1.76
*p < 0.05; yp < 0.001.
Racial discordance in spirometry 709with a reproducible test), predicted FVC and FEV1 dropped
by 62.5 cc and 52 cc respectively. Knudson, Glindmeyer,
and Crapo used three acceptable curves, while Morris
required only two, which could account for many patients
being reclassified from normal to restrictive by NHANES III.
There were also different methods used to calculate the
appropriate start- and end of test criteria, as the ATS rec-
ommended using different techniques over time. Lastly,
the Crapo reference equation utilized the largest FVC and
FEV1 sum rather than the largest value from separate
efforts, as recommended by ATS. This may result in a 50-mL
reduction in the FVC.3 Other factors, including the smaller
sized data sets, different age ranges, and older dates of
publication (cohort effect) could also contribute to
discordance.
The use of a single, standard correction factor to adjust
for race has been questioned. In keeping with prior stud-
ies,8e12,16e18 the NHANES III authors found that Africane
Americans have a lower FEV1 and FVC and an FEV1/FVC
ratio that is similar to or greater than that found in
Caucasians. They agreed that the adjustment factor of
12e15% does approximate the difference between the two
groups, with potential for some error at certain ages and
heights. Enright and colleagues also showed that the
commonly used 12% adjustment factor may not apply to
elderly AfricaneAmerican patients (>65 years), and may
overestimate predicted values in this age group.15 Others
feel the wide variation in racial differences seen across
studies makes using a single conversion factor inappro-
priate.19 The 2005 ATS/ERS consensus recommendations
state that in certain situations a racial adjustment factor
may be used, but that specific race/ethnic equations are
preferred.
We anticipated that the more recently published, race
specific equations from Glindmeyer’s study would have
superior concordance to NHANES III than older referenceequations that used a racial correction factor. As such, we
were surprised to find that when we compared Crapo with
a correction factor to NHANES III, the agreement was
excellent, with less discordance than Glindmeyer. Glind-
meyer only evaluated patients up to the age of 65, while
Crapo and NHANES III evaluated older patients. We found
that age greater than 65 was predictive of discordance
(Table 2), which may explain why Glindmeyer had unex-
pectedly less agreement with NHANES III than Crapo,
despite using equations based on AfricaneAmericans.
Therefore, while the discordance in our study may in part
be attributable to using standard correction factors, the
above discrepancy between Crapo and Glindmeyer points
to a greater impact of age.
Ultimately, racial differences in biomedical data can be
difficult to interpret due to the necessary assumptions
involved.28,29 Identity is not fixed or easily determined (i.e.
biracial, multiracial; self-identification can be dynamic).29
Categorizations based on skin color, language spoken, or
country of origin, are imprecise and may change over time.
Individual biases may also affect classification.28 We lack an
adequate understanding of the complex factors that
account for differences in perceived groups (socioeconomic
status, access to healthcare, quality of healthcare, racism,
and exposure to occupational or environmental hazards).29
A study by Harik-Khan et al30 failed to completely account
for racial differences in lung function in AfricaneAmerican
patients based on physical or socioeconomic factors alone.
With regards to standardized medical reference equations
and race, multiple factors can make an apparently
homogenous population of ‘‘AfricaneAmericans’’ heterog-
enous.31 This can limit the reliability of race based equa-
tions and racial conversion factors.
Our study has several limitations. This is a retrospective
analysis of all screening pulmonary function tests done in
our clinic over a seven year period. Our hospital serves
710 J. Collen et al.military beneficiaries, which include active duty service
members, retirees, and their dependants. Our hospital is
located in a large US city, and many of our beneficiaries live
in the surrounding area. However, we also serve patients
referred from other military facilities around the country as
well as from overseas. Additionally, our population of
AfricaneAmericans had an average body mass index of
28.9, which may be higher than the body mass index found
in other populations, and potentially not generalizable to
other US AfricaneAmericans. It is unclear what impact
these factors had on our results.
In summary, we have presented the first study showing
that discordance and spirometric misclassification (with all
of the potential for incorrectly directed evaluation and
management) exists in AfricaneAmericans when older
reference equations are applied as opposed to NHANES III.
The NHANES III data set is large and includes a broad
demographic range sampled from across the United States,
with specific equations derived from Caucasian, Hispanic,
and AfricaneAmerican patients. As we have shown, there
are significant and clinically relevant differences in
prediction equation results for AfricaneAmericans when
using NHANES III, compared to older reference equations. In
the absence of reference values derived specifically from
the patient population expected to utilize a given lab,
drawing reference values from a large and racially diverse
population, like the one used in NHANES III, seems prudent.
Physicians need to be aware of the potential for spirometric
discordance when interpreting spirometry in Africane
American patients.Conflict of interest
The authors have no conflicts of interest to disclose.
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